Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 5 3 2019
medline: 24 1 2020
entrez: 5 3 2019
Statut: ppublish

Résumé

To use the concept of benchmarking to establish robust and standardized outcome references after pancreatico-duodenectomy (PD). Best achievable results after PD are unknown. Consequently, outcome comparisons among different cohorts, centers or with novel surgical techniques remain speculative. This multicenter study analyzes consecutive patients (2012-2015) undergoing PD in 23 international expert centers in pancreas surgery. Outcomes in patients without significant comorbidities and major vascular resection (benchmark cases) were analyzed to establish 20 outcome benchmarks for PD. These benchmarks were tested in a cohort with a poorer preoperative physical status (ASA class ≥3) and a cohort treated by minimally invasive approaches. Two thousand three hundred seventy-five (38%) low-risk cases out of a total of 6186 PDs were analyzed, disclosing low in-hospital mortality (≤1.6%) but high morbidity, with a 73% benchmark morbidity rate cumulated within 6 months following surgery. Benchmark cutoffs for pancreatic fistulas (B-C), severe complications (≥ grade 3), and failure-to-rescue rate were 19%, 30%, and 9%, respectively. The ASA ≥3 cohort showed comparable morbidity but a higher in hospital-mortality (3% vs 1.6%) and failure-to-rescue rate (16% vs 9%) than the benchmarks. The proportion of benchmark cases performed varied greatly across centers and continents for both open (9%-93%) and minimally invasive (11%-62%) PD. Centers operating mostly on complex PD cases disclosed better results than those with a majority of low-risk cases. The proposed outcome benchmarks for PD, established in a large-scale international patient cohort and tested in 2 different cohorts, may allow for meaningful comparisons between different patient cohorts, centers, countries, and surgical techniques.

Sections du résumé

OBJECTIVE
To use the concept of benchmarking to establish robust and standardized outcome references after pancreatico-duodenectomy (PD).
BACKGROUND
Best achievable results after PD are unknown. Consequently, outcome comparisons among different cohorts, centers or with novel surgical techniques remain speculative.
METHODS
This multicenter study analyzes consecutive patients (2012-2015) undergoing PD in 23 international expert centers in pancreas surgery. Outcomes in patients without significant comorbidities and major vascular resection (benchmark cases) were analyzed to establish 20 outcome benchmarks for PD. These benchmarks were tested in a cohort with a poorer preoperative physical status (ASA class ≥3) and a cohort treated by minimally invasive approaches.
RESULTS
Two thousand three hundred seventy-five (38%) low-risk cases out of a total of 6186 PDs were analyzed, disclosing low in-hospital mortality (≤1.6%) but high morbidity, with a 73% benchmark morbidity rate cumulated within 6 months following surgery. Benchmark cutoffs for pancreatic fistulas (B-C), severe complications (≥ grade 3), and failure-to-rescue rate were 19%, 30%, and 9%, respectively. The ASA ≥3 cohort showed comparable morbidity but a higher in hospital-mortality (3% vs 1.6%) and failure-to-rescue rate (16% vs 9%) than the benchmarks. The proportion of benchmark cases performed varied greatly across centers and continents for both open (9%-93%) and minimally invasive (11%-62%) PD. Centers operating mostly on complex PD cases disclosed better results than those with a majority of low-risk cases.
CONCLUSION
The proposed outcome benchmarks for PD, established in a large-scale international patient cohort and tested in 2 different cohorts, may allow for meaningful comparisons between different patient cohorts, centers, countries, and surgical techniques.

Identifiants

pubmed: 30829701
doi: 10.1097/SLA.0000000000003223
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-218

Commentaires et corrections

Type : CommentIn

Auteurs

Patricia Sánchez-Velázquez (P)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Xavier Muller (X)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Giuseppe Malleo (G)

Department of Surgery, University Hospital of Verona, "Pancreas Institute," Verona, Italy.

Joon-Seong Park (JS)

Department of Surgery, Yonsei Severance Hospital, Seoul, South Korea.

Ho-Kyoung Hwang (HK)

Department of Surgery, Yonsei Severance Hospital, Seoul, South Korea.

Niccolò Napoli (N)

Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.

Ammar A Javed (AA)

The John L. Cameron Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Yosuke Inoue (Y)

Department of Surgery, Cancer Institute Hospital, Tokyo, Japan.

Nassiba Beghdadi (N)

Department of Surgery, Hôpital Beaujon, Clichy, France.

Marit Kalisvaart (M)

Department of Surgery, Queen Elizabeth Hospital, Birmingham, UK.

Emanuel Vigia (E)

Department of Surgery, Curry Cabral Hospital, CHLC, Lisboa, Portugal.

Carrie D Walsh (CD)

Department of Surgery, Thomas Jefferson University, Philadelphia, PA.

Brendan Lovasik (B)

Department of Surgery, Emory University School of Medicine, Atlanta, GA.

Juli Busquets (J)

Department of Surgery, University Hospital of Bellvitge, Barcelona, Spain.

Chiara Scandavini (C)

Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.

Fabien Robin (F)

Department of Digestive Surgery, E Herriot University Hospital, HCL, UCBL1, Lyon, France.

Hideyuki Yoshitomi (H)

Department of General Surgery, Chiba University Hospital, Chiba Japan.

Tara M Mackay (TM)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Olivier R Busch (OR)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Hermien Hartog (H)

Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.

Stefan Heinrich (S)

Department of Surgery, University Hospital of Mainz, Mainz, Germany.

Ana Gleisner (A)

Department of Surgery, University of Colorado, Denver, CO.

Julie Perinel (J)

Department of Surgery, E Herriot University Hospital, HCL, Lyon, France.

Michael Passeri (M)

Department of Surgery, Carolina's Health Care Hospital, NC.

Nuria Lluis (N)

Department of Surgical Oncology Miami Cancer Institute, Miami, FL.

Dimitri A Raptis (DA)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Christoph Tschuor (C)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Christian E Oberkofler (CE)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Michelle L DeOliveira (ML)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Henrik Petrowsky (H)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

John Martinie (J)

Department of Surgery, Carolina's Health Care Hospital, NC.

Horacio Asbun (H)

Department of Surgical Oncology Miami Cancer Institute, Miami, FL.

Mustapha Adham (M)

Department of Surgery, E Herriot University Hospital, HCL, Lyon, France.

Richard Schulick (R)

Department of Surgery, University of Colorado, Denver, CO.

Hauke Lang (H)

Department of Surgery, University Hospital of Mainz, Mainz, Germany.

Bas Groot Koerkamp (BG)

Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.

Marc G Besselink (MG)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Ho-Seong Han (HS)

Department of Surgery, Seoul National University Bundang Hospital, Seoul, South Korea.

Masaru Miyazaki (M)

Department of Surgery, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.

Cristina R Ferrone (CR)

Department of Surgery, Massachusetts General Hospital, Boston, MA.

Carlos Fernández-Del Castillo (C)

Department of Surgery, Massachusetts General Hospital, Boston, MA.

Keith D Lillemoe (KD)

Department of Surgery, Massachusetts General Hospital, Boston, MA.

Laurent Sulpice (L)

Department of Digestive Surgery, E Herriot University Hospital, HCL, UCBL1, Lyon, France.

Karim Boudjema (K)

Department of Digestive Surgery, E Herriot University Hospital, HCL, UCBL1, Lyon, France.

Marco Del Chiaro (M)

Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.

Joan Fabregat (J)

Department of Surgery, University Hospital of Bellvitge, Barcelona, Spain.

David A Kooby (DA)

Department of Surgery, Emory University School of Medicine, Atlanta, GA.

Peter Allen (P)

Department of Surgery, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY.

Harish Lavu (H)

Department of Surgery, Thomas Jefferson University, Philadelphia, PA.

Charles J Yeo (CJ)

Department of Surgery, Thomas Jefferson University, Philadelphia, PA.

Eduardo Barroso (E)

Department of Surgery, Curry Cabral Hospital, CHLC, Lisboa, Portugal.

Keith Roberts (K)

Department of Surgery, Queen Elizabeth Hospital, Birmingham, UK.

Paolo Muiesan (P)

Department of Surgery, Queen Elizabeth Hospital, Birmingham, UK.

Alain Sauvanet (A)

Department of Surgery, Hôpital Beaujon, Clichy, France.

Akio Saiura (A)

Department of Surgery, Cancer Institute Hospital, Tokyo, Japan.

Christopher L Wolfgang (CL)

The John L. Cameron Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

John L Cameron (JL)

The John L. Cameron Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Ugo Boggi (U)

Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.

Dong-Sup Yoon (DS)

Department of Surgery, Yonsei Severance Hospital, Seoul, South Korea.

Claudio Bassi (C)

Department of Surgery, University Hospital of Verona, "Pancreas Institute," Verona, Italy.

Milo A Puhan (MA)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Pierre-Alain Clavien (PA)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH